Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 3 NIH 1 NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Vaginal Neoplasms 1 Urethral Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Radiation Injuries 1 Radiation Fibrosis Syndrome 1 Prostatic Neoplasms 1 Postoperative Complications 1 Ovarian Germ Cell Cancer 1 Osteosarcoma 1

Interventions

Ifosfamide 5 Doxorubicin 4 Specimen Handling 3 Methotrexate 3 Etoposide 3 Cisplatin 3 Sorafenib 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 sodium thiosulfate 1 sargramostim 1 pepinemab 1 peginterferon alfa-2b 1 mifamurtide 1 merphos 1 lorukafusp alfa 1 irinotecan sucrosofate 1 imetelstat 1 etoposide phosphate 1 Zoledronic Acid 1 X-Rays 1 Thrombopoietin 1 Thoracotomy 1 Thoracostomy 1 Thoracoscopy 1 Surgical Procedures, Operative 1 Reverse Transcriptase Polymerase Chain Reaction 1 Restraint, Physical 1 Razoxane 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Osteosarcoma × Surgical Procedures, Operative × Clear all

NCT04890067 2026-03-27

ISG Os2Oss

Italian Sarcoma Group

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡